Elevated BCRP/ABCG2 expression confers acquired resistance to gefitinib in wild-type EGFR-expressing cells.
Chen YJ, Huang WC, Wei YL, Hsu SC, Yuan P, Lin HY, Wistuba II, Lee JJ, Yen CJ, Su WC, Chang KY, Chang WC, Chou TC, Chou CK, Tsai CH, Hung MC.
Chen YJ, et al. Among authors: chang ky, chang wc.
PLoS One. 2011;6(6):e21428. doi: 10.1371/journal.pone.0021428. Epub 2011 Jun 23.
PLoS One. 2011.
PMID: 21731744
Free PMC article.